New Zealand markets open in 8 hours 29 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
421.93+3.38 (+0.81%)
At close: 04:05PM EDT
421.93 +0.06 (+0.01%)
After hours: 04:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.51B
Enterprise value 11.94B
Trailing P/E N/A
Forward P/E 28.01
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)4.42
Price/book (mrq)1.40
Enterprise value/revenue 4.16
Enterprise value/EBITDA -4.85

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-44.95%
S&P500 52-week change 3-16.88%
52-week high 3798.97
52-week low 3406.24
50-day moving average 3505.21
200-day moving average 3560.87

Share statistics

Avg vol (3-month) 3146.81k
Avg vol (10-day) 3179.56k
Shares outstanding 524.63M
Implied shares outstanding 6N/A
Float 821.2M
% held by insiders 114.46%
% held by institutions 180.12%
Shares short (30 Aug 2022) 4367.63k
Short ratio (30 Aug 2022) 43.17
Short % of float (30 Aug 2022) 41.74%
Short % of shares outstanding (30 Aug 2022) 41.24%
Shares short (prior month 28 Jul 2022) 4335.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin -67.66%
Operating margin (ttm)20.68%

Management effectiveness

Return on assets (ttm)2.67%
Return on equity (ttm)-18.93%

Income statement

Revenue (ttm)2.87B
Revenue per share (ttm)96.13
Quarterly revenue growth (yoy)-3.50%
Gross profit (ttm)1.67B
EBITDA 725.63M
Net income avi to common (ttm)-1.94B
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.97B
Total cash per share (mrq)66.26
Total debt (mrq)1.39B
Total debt/equity (mrq)15.60
Current ratio (mrq)5.30
Book value per share (mrq)300.45

Cash flow statement

Operating cash flow (ttm)484.8M
Levered free cash flow (ttm)340.62M